BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31349478)

  • 1. PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting.
    Biscaglia F; Quarta S; Villano G; Turato C; Biasiolo A; Litti L; Ruzzene M; Meneghetti M; Pontisso P; Gobbo M
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109762. PubMed ID: 31349478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles.
    Jha S; Ramadori F; Quarta S; Biasiolo A; Fabris E; Baldan P; Guarino G; Ruvoletto M; Villano G; Turato C; Gatta A; Mancin F; Pontisso P; Scrimin P
    Bioconjug Chem; 2017 Jan; 28(1):222-229. PubMed ID: 27771945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus.
    Zhang Q; Zhang X; Chen T; Wang X; Fu Y; Jin Y; Sun X; Gong T; Zhang Z
    Nanoscale; 2015; 7(20):9298-310. PubMed ID: 25945919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
    Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
    Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
    Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive
    Nicolson F; Andreiuk B; Andreou C; Hsu HT; Rudder S; Kircher MF
    Theranostics; 2019; 9(20):5899-5913. PubMed ID: 31534527
    [No Abstract]   [Full Text] [Related]  

  • 8. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells.
    Balasso A; Salmaso S; Pontisso P; Rosato A; Quarta S; Malfanti A; Mastrotto F; Caliceti P
    Eur J Pharm Sci; 2017 May; 103():104-115. PubMed ID: 28192167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic immunoassay for cancer biomarker detection based on surface-enhanced resonance Raman scattering from coupled plasmonic nanostructures.
    Rong Z; Wang C; Wang J; Wang D; Xiao R; Wang S
    Biosens Bioelectron; 2016 Oct; 84():15-21. PubMed ID: 27149164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
    Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
    Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex disparity in viral load, inflammation and liver damage in transgenic mice carrying full hepatitis B virus genome with the W4P mutation in the preS1 region.
    Lee SA; Lee SY; Choi YM; Kim H; Kim BJ
    World J Gastroenterol; 2018 Mar; 24(10):1084-1092. PubMed ID: 29563753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-Enhanced Resonance Raman Scattering-Guided Brain Tumor Surgery Showing Prognostic Benefit in Rat Models.
    Han L; Duan W; Li X; Wang C; Jin Z; Zhai Y; Cao C; Chen L; Xu W; Liu Y; Bi YY; Feng J; Mao Y; Yue Q; Zhang XY; Li C
    ACS Appl Mater Interfaces; 2019 May; 11(17):15241-15250. PubMed ID: 30896915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma.
    Zhao J; Vykoukal J; Abdelsalam M; Recio-Boiles A; Huang Q; Qiao Y; Singhana B; Wallace M; Avritscher R; Melancon MP
    Nanotechnology; 2014 Oct; 25(40):405101. PubMed ID: 25211057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
    Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
    Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and biological activity of poly(arginine)-derived cancer-targeting peptides in HepG2 liver cancer cells.
    Joseph SC; Blackman BA; Kelly ML; Phillips M; Beaury MW; Martinez I; Parronchi CJ; Bitsaktsis C; Blake AD; Sabatino D
    J Pept Sci; 2014 Sep; 20(9):736-45. PubMed ID: 24931620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SERPINB3 in hepatocellular carcinoma.
    Pontisso P
    Ann Hepatol; 2014; 13(6):722-7. PubMed ID: 25332258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Au(iii)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells.
    Brustolin L; Pettenuzzo N; Nardon C; Quarta S; Marchiò L; Biondi B; Pontisso P; Fregona D
    Dalton Trans; 2019 Nov; 48(42):16017-16025. PubMed ID: 31599279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly narrow nanogap-containing Au@Au core-shell SERS nanoparticles: size-dependent Raman enhancement and applications in cancer cell imaging.
    Hu C; Shen J; Yan J; Zhong J; Qin W; Liu R; Aldalbahi A; Zuo X; Song S; Fan C; He D
    Nanoscale; 2016 Jan; 8(4):2090-6. PubMed ID: 26701141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide.
    Biscaglia F; Rajendran S; Conflitti P; Benna C; Sommaggio R; Litti L; Mocellin S; Bocchinfuso G; Rosato A; Palleschi A; Nitti D; Gobbo M; Meneghetti M
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28945012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R; Kawano T; Kang JH; Murata M
    World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.